Please provide your email address to receive an email when new articles are posted on . One-stage approach for periprosthetic joint infection had an efficacy of 98% vs. 92% for two-stage approach. One ...
Please provide your email address to receive an email when new articles are posted on . Patients had no drug-related complications with dalbavancin. Results showed 89% of patients were infection free ...
Peptilogics' PLG0206 is a first-in-class anti-biofilm drug candidate being studied in patients with prosthetic joint infection (PJI), the first of multiple potential medical device-related infections ...
PITTSBURGH, Pa.--(BUSINESS WIRE)--Peptilogics, a biotech company engineering peptide therapeutics to improve the treatment landscape for patients with life-threatening diseases, will present one ...
PITTSBURGH--(BUSINESS WIRE)--Peptilogics, a biotech company engineering peptide therapeutics to improve the treatment landscape for patients with life-threatening diseases, today announced that the ...
Personal tragedies involving family and friends motivated this CEO to launch Peptilogics. When thinking of life-threatening surgical risks, hip or knee replacement does not immediately spring to mind.
One-stage versus two-stage revision of prosthetic joint infection (PJI): It's a topic that has been up for debate in the orthopedic surgery community. A clinical practice guideline from the Infectious ...
Measurement of plasma D-dimer levels – a test more commonly used to detect blood-clotting disorders – can provide useful information when making the difficult diagnosis of periprosthetic joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results